The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: A distinct increasing trend with birth-cohort effect

Blood

Volumn 116, Issue 22, 2010, Pages 4430-4435

  Wu, Shang Ju ^a   Huang, Shang Yi ^a   Lin, Chien Ting ^a   Lin Jr , Yu ^b   Chang, Chee Jen ^b   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GROUPS BY AGE; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; JAPANESE; LIFESTYLE; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TAIWAN;

EID: 78649469964     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-285221     Document Type: Article

References (35)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med. 1995;333(16):1052-1057.
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89(11): 3909-3918.
3. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9(7):717-720.
4. Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer. 2000;89(7):1586-1592.
5. Goldin LR, Slager SL. Familial CLL: genes and environment. Hematology Am Soc Hematol Educ Program. 2007:339-345.
6. Dores GM, Anderson WF, Curtis RE, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol. 2007;139(5):809-819.
7. The World Health Organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50(9):696-702.
8. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer. 1998;83(4):806-812.
9. Huang SY, Yao M, Tang JL, et al. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer. 2007;110(4):896-905.
10. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987;6(4):469-481. (Pubitemid 17110909)
11. Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med. 1982;1(3):245-259.
12. Hsu C, Shen YC, Cheng CC, Hong RL, Chang CJ, Cheng AL. Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-periodcohort analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):856-861.
13. Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, Cheng AL. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1986-1990.
14. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents Vol. VIII. Lyon, France: IARC Scientific Publications; 2002.
15. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer. 2008;122(6):1418-1421.
16. Miligi L, Costantini AS, Benvenuti A, et al. Personal use of hair dyes and hematolymphopoietic malignancies. Arch Environ Occup Health. 2005; 60(5):249-256.
17. Linet MS, Devesa SS, Morgan GJ. The leukemias. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006: 841-871.
18. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC. Environmental tobacco smoke and risk of adult leukemia. Epidemiology. 2005;16(5): 672-680. (Pubitemid 41233622)
19. Miligi L, Seniori Costantini A, Crosignani P, et al. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med. 1999; 36(1):60-69.
20. Tynes T, Haldorsen T. Residential and occupational exposure to 50 Hz magnetic fields and hematological cancers in Norway. Cancer Causes Control. 2003;14(8):715-720. (Pubitemid 37463884)
21. Silver SR, Hiratzka SL, Schubauer-Berigan MK, Daniels RD. Chronic lymphocytic leukemia radiogenicity: a systematic review. Cancer Causes Control. 2007;18(10):1077-1093.
22. Tien HF, Wang CH, Lee FY, et al. Cytogenetic study of acute lymphoblastic leukemia and its correlation with immunophenotype and genotype. Cancer Genet Cytogenet. 1992;59(2):191-198.
23. Tien HF, Wang CH, Su IJ, et al. A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7-morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients. Leuk Res. 1990;14(6): 515-523.
24. Chang JJ, Liu CJ, Liu JH, Chiou TJ, Tzeng CH, Chen PM. Monosomy 21 in two patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1992;61(2):122-125.
25. Turesson I, Linet MS, Bjorkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer. 2007;121(10):2260-2266.
26. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001;92(5):1325-1330.
27. Pan JW, Cook LS, Schwartz SM, Weis NS. Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control. 2002;13(9):791-795.
28. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10): 1204-1210.
29. Slager SL, Goldin LR, Strom SS, et al. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev;19(4): 1098-1102.
30. Steward BW, Kleihues P. World Cancer Report. Lyon, France: IARC Press; 2003.
31. Sng I. Malignant lymphoma - a changing spectrum. Ann Acad Med Singapore. 2009;38(10): 837-839.
32. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. World Health Organization Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues. 2001.
33. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ III. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer. 2004;101(11): 2667-2674.
34. Levi F, Te VC, Randimbison L, La Vecchia C. Incidence of multiple myeloma in Olmsted County, Minnesota. Cancer. 2005;104(2):442.
35. Aozasa K, Ueda T, Tamai M, Tsujimura T. Hodgkin's disease in Osaka, Japan (1964-1985). Eur J Cancer Clin Oncol. 1986;22(9):1117-1119.